Medicine and Dentistry
Rectum Cancer
100%
Anastomosis Leakage
52%
Surgery
45%
Chemoradiotherapy
26%
Total Mesorectal Excision
25%
Cancer Surgery
23%
Colorectal Cancer
23%
Surgical Anastomosis
21%
Systematic Review
21%
Stoma
18%
Colon Cancer
17%
Colorectal Anastomosis
17%
Patient Referral
15%
Radiation Therapy
15%
Primary Health Care
15%
Writing
15%
Neoadjuvant Therapy
14%
Overall Survival
12%
Magnetic Resonance Imaging
12%
Meta-Analysis
11%
Pelvic Floor
11%
Randomized Controlled Trial
11%
General Practitioner
11%
Health Care Cost
11%
Surgeon
10%
Cross Sectional Study
10%
Secondary Care
10%
Bevacizumab
10%
Surgical Margin
9%
Neoplasm
9%
Oncology
9%
Quality of Life
8%
Capecitabine
8%
Wound
8%
Survival Rate
8%
Re-Irradiation
7%
Oxaliplatin
7%
Disease Free Survival
7%
Recurrence Risk
7%
Metastatic Carcinoma
7%
Malignant Neoplasm
7%
Systemic Therapy
7%
Recurrent Disease
7%
Liver Metastasis
6%
Learning Curve
6%
Mortality Rate
6%
Pelvis
6%
Cancer Therapy
6%
Microbiome
6%
Randomized Clinical Trial
6%
Keyphrases
Colorectal Cancer
23%
Anastomotic Leakage
21%
Transanal Total Mesorectal Excision (taTME)
19%
Locally Advanced Rectal Cancer
15%
Colorectal Surgery
12%
Surgeons
11%
Stage IV Rectal Cancer
10%
Robot-assisted
10%
Short-course Radiotherapy
10%
Microbiome
10%
Locally Recurrent Rectal Cancer
10%
Computed Tomography
9%
Neoadjuvant Therapy
9%
Neoadjuvant Chemoradiotherapy (nCRT)
8%
Systemic Therapy
7%
Bevacizumab
7%
Anastomosis
7%
Meta-analysis
6%
Colorectal Anastomosis
6%
Leakage Rate
6%
Resection
6%
Abdomen
5%
Systematic Meta-analysis
5%
Interval to Surgery
5%
Surgical Margin
5%
Carcinoembryonic Antigen
5%
Decision Support Software
5%
Circumferential Resection Margin
5%
Biobank
5%
Predictive Value
5%
Oncology
5%
Cost Analysis
5%
Circular Stapler
5%
Colorectal Anastomotic Leakage
5%
Perineal Wound Reconstruction
5%
Lotus Petal Flap
5%
Qualitative Mixed Methods
5%
Radical Treatment
5%
Follow-up Data
5%
Biological Samples
5%
Treatment Schedule
5%
Neoadjuvant Bevacizumab
5%
Restaging
5%
Oxaliplatin
5%
Retrospective Longitudinal Study
5%
Social Networks
5%
Biodegradeable
5%
Ablation
5%
Fluorescence Imaging
5%
Clinical Data
5%
